nodes	percent_of_prediction	percent_of_DWPC	metapath
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—ID2—ocular cancer	0.0342	0.0342	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—E2F5—ocular cancer	0.0317	0.0317	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—E2F4—ocular cancer	0.031	0.031	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—RBL1—ocular cancer	0.0304	0.0304	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—MAML2—ocular cancer	0.0301	0.0301	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CCND3—ocular cancer	0.0279	0.0279	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—HRAS—ocular cancer	0.0271	0.0271	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—RBBP4—ocular cancer	0.0264	0.0264	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—CCND2—ocular cancer	0.0258	0.0258	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—TFDP1—ocular cancer	0.0245	0.0245	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—AKT1—ocular cancer	0.0239	0.0239	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—HDAC1—ocular cancer	0.022	0.022	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CDK6—ocular cancer	0.0208	0.0208	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—HDAC1—ocular cancer	0.02	0.02	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—E2F1—ocular cancer	0.0181	0.0181	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—CDK4—ocular cancer	0.0173	0.0173	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.0156	0.0156	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.0153	0.0153	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CDC25A—ocular cancer	0.0152	0.0152	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—ocular cancer	0.0144	0.0144	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC1—ocular cancer	0.0144	0.0144	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—HDAC1—ocular cancer	0.0142	0.0142	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—HDAC1—ocular cancer	0.0132	0.0132	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CDC25A—ocular cancer	0.0131	0.0131	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—RB1—ocular cancer	0.0128	0.0128	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—ocular cancer	0.0128	0.0128	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—CDKN1B—ocular cancer	0.0117	0.0117	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—CDKN1B—ocular cancer	0.0105	0.0105	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—CDK2—ocular cancer	0.0101	0.0101	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—CDKN1B—ocular cancer	0.00999	0.00999	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—MDM2—ocular cancer	0.00994	0.00994	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—MDM2—ocular cancer	0.00958	0.00958	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—ocular cancer	0.00955	0.00955	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—EP300—ocular cancer	0.00925	0.00925	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—EP300—ocular cancer	0.00877	0.00877	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.00865	0.00865	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.00843	0.00843	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—HRAS—ocular cancer	0.00838	0.00838	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—EP300—ocular cancer	0.00797	0.00797	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—E2F5—ocular cancer	0.00792	0.00792	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—E2F4—ocular cancer	0.00775	0.00775	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CCND1—ocular cancer	0.00774	0.00774	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—RB1—ocular cancer	0.0077	0.0077	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—RBL1—ocular cancer	0.00761	0.00761	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.00744	0.00744	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—AKT1—ocular cancer	0.0074	0.0074	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00712	0.00712	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—AKT1—ocular cancer	0.00711	0.00711	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—MDM2—ocular cancer	0.00657	0.00657	CbGpPWpGaD
Drostanolone—AR—Gene Expression—SF3B1—ocular cancer	0.0065	0.0065	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00643	0.00643	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ocular cancer	0.00623	0.00623	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.00614	0.00614	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—TFDP1—ocular cancer	0.00613	0.00613	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00612	0.00612	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.00597	0.00597	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.0059	0.0059	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.0058	0.0058	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.00573	0.00573	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CCND1—ocular cancer	0.00572	0.00572	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.00568	0.00568	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CDKN1A—ocular cancer	0.00553	0.00553	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.00528	0.00528	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—EP300—ocular cancer	0.00526	0.00526	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00509	0.00509	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00505	0.00505	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.005	0.005	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.00499	0.00499	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.00495	0.00495	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—MAML2—ocular cancer	0.00487	0.00487	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00481	0.00481	CbGpPWpGaD
Drostanolone—AR—Gene Expression—EIF1AX—ocular cancer	0.00458	0.00458	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PSPH—ocular cancer	0.00435	0.00435	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00434	0.00434	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—AKT1—ocular cancer	0.0043	0.0043	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.0043	0.0043	CbGpPWpGaD
Drostanolone—AR—Gene Expression—E2F5—ocular cancer	0.00381	0.00381	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00375	0.00375	CbGpPWpGaD
Drostanolone—AR—Gene Expression—E2F4—ocular cancer	0.00373	0.00373	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.0037	0.0037	CbGpPWpGaD
Drostanolone—AR—Gene Expression—RPL39—ocular cancer	0.00366	0.00366	CbGpPWpGaD
Drostanolone—AR—Gene Expression—RBL1—ocular cancer	0.00366	0.00366	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00356	0.00356	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—HDAC1—ocular cancer	0.00356	0.00356	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00345	0.00345	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.00343	0.00343	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00336	0.00336	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00325	0.00325	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00322	0.00322	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00319	0.00319	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—AKT1—ocular cancer	0.00318	0.00318	CbGpPWpGaD
Drostanolone—AR—Gene Expression—RBBP4—ocular cancer	0.00317	0.00317	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.0031	0.0031	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00301	0.00301	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.003	0.003	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00297	0.00297	CbGpPWpGaD
Drostanolone—AR—Gene Expression—TFDP1—ocular cancer	0.00295	0.00295	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00286	0.00286	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00259	0.00259	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00249	0.00249	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00248	0.00248	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.00247	0.00247	CbGpPWpGaD
Drostanolone—AR—Gene Expression—MAML2—ocular cancer	0.00234	0.00234	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.00212	0.00212	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.00208	0.00208	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00173	0.00173	CbGpPWpGaD
Drostanolone—AR—Gene Expression—HDAC1—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Drostanolone—AR—Gene Expression—CDKN2B—ocular cancer	0.00154	0.00154	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GNA11—ocular cancer	0.00137	0.00137	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GNAQ—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—MYC—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Drostanolone—AR—Gene Expression—MYC—ocular cancer	0.000596	0.000596	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—EP300—ocular cancer	0.000457	0.000457	CbGpPWpGaD
Drostanolone—AR—Gene Expression—AKT1—ocular cancer	0.000413	0.000413	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKT1—ocular cancer	0.000276	0.000276	CbGpPWpGaD
